Form 4: IGM Biosciences Executive Lisa Lynn Decker Sells Shares to Cover Tax Obligations

Lisa Lynn Decker, Chief Business Officer of IGM Biosciences, sold shares of common stock on March 13 and 14, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Lisa Lynn Decker, Chief Business Officer of IGM Biosciences, sold shares of the company's common stock on March 13 and 14, 2024.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• On March 13, 2024, 1,798 shares were sold at a weighted average price of $9.8752, with individual prices ranging from $9.625 to $10.01.
• On March 14, 2024, 1,578 shares were sold at a weighted average price of $10.1705, with individual prices ranging from $9.80 to $10.43.
• Following these transactions, Decker directly owns 61,006 shares of IGM Biosciences common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock sales by an executive to cover tax obligations. It doesn't inherently indicate positive or negative sentiment regarding the company's performance.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax obligations. The filing provides transparency into these transactions.

Stakeholder Impact

• The stock sales by the Chief Business Officer could have a minor impact on shareholders due to the slight dilution of shares.

Key Dates